Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Acer Therapeutics Inc. (ACER) had Income from Continuous Operations of $-14.73M for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
$0.37M |
|
$-14.73M |
|
$0.08M |
|
$0.29M |
|
$13.25M |
|
$-12.88M |
|
$-1.85M |
|
$-14.73M |
|
$-14.73M |
|
$-14.73M |
|
|
Income from Continuous Operations |
$-14.73M |
$-14.73M |
|
$-14.73M |
|
$-12.88M |
|
$-12.86M |
|
24.46M |
|
24.46M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$6.14M |
|
$0.04M |
|
$7.86M |
|
$14.00M |
|
$61.67M |
|
-- |
|
$0.08M |
|
$61.75M |
|
$-47.74M |
|
$-55.39M |
|
$-47.74M |
|
24.46M |
|
| Cash Flow Statement Financials | |
$-28.91M |
|
$-0.00M |
|
$27.17M |
|
$2.33M |
|
$0.59M |
|
$-1.73M |
|
$0.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.99 |
|
77.46% |
|
-3463.77% |
|
-3463.77% |
|
-- |
|
-3962.26% |
|
-3962.26% |
|
$-28.91M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.02 |
|
-- |
|
-- |
|
30.85% |
|
26.59% |
|
-105.21% |
|
30.85% |
|
$-1.95 |
|
$-1.18 |
|
$-1.18 |
|